Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK (NCT04181970)
Observational Study, for Quality Assessment, of Sarcoma As a Model to Improve Diagnosis and Clinical Care of Rare Tumors Through a European and Latin American Multidisciplinary NETWORK
🩺 Plain-English Summary (8th-Grade Level)
Post-authorisation, multicentric, observational, retrospective and prospective study to assess quality of care of sarcoma patients in expert and non-expert centers by analysing correlation of quality items and outcomes such as relapse free survival, overall survival, percentage of amputation, etc. Expert pathology peer review will be performed to detect differences between expert and non-expert centers as well as differences in treatment and patient prognosis. Tumor samples of 4 types of sarcoma would also be included in translational research to detect biomarkers and produce preclinical models.
Who can join: Review the eligibility criteria below.
Location: Alexander Fleming Sa — Buenos Aires
Age range: 18 Years to 120 Years
🧪 Interventions in This Study
- Quality assessment (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (9 Sites)
- Alexander Fleming Sa — Buenos Aires,
- A C Camargo — São Paulo,
- Hospital San Vicente de Paúl — Heredia,
- Centre Leon Berard — Lyon,
- Instituto Ortopedico Rizzoli — Bologna,
- Insituto Nazionale Di Tumore — Milan,
- Instituto Nacional de Cancerología — Mexico City,
- Instituo Nacional de enfermedades Neoplásicas — Surquillo,
- Fundación Jiménez Díaz — Madrid, Madrid
📞 Contact the Study Coordinator
Phone: +34 910908102
Email: martamartinruiz@atbsarc.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Soft-tissue Sarcoma
Explore by condition: All Soft-tissue Sarcoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.